141 related articles for article (PubMed ID: 22697064)
1. Platelet rich plasma in tendinopathies: how to explain the failure.
Abate M; Di Gregorio P; Schiavone C; Salini V; Tosi U; Muttini A
Int J Immunopathol Pharmacol; 2012; 25(2):325-34. PubMed ID: 22697064
[TBL] [Abstract][Full Text] [Related]
2. Platelet rich placebo? Evidence for platelet rich plasma in the treatment of tendinopathy and augmentation of tendon repair.
Hall MP; Ward JP; Cardone DA
Bull Hosp Jt Dis (2013); 2013; 71(1):54-9. PubMed ID: 24032584
[TBL] [Abstract][Full Text] [Related]
3. Autologous growth factor injections in chronic tendinopathy: a systematic review.
de Vos RJ; van Veldhoven PL; Moen MH; Weir A; Tol JL; Maffulli N
Br Med Bull; 2010; 95():63-77. PubMed ID: 20197290
[TBL] [Abstract][Full Text] [Related]
4. Long-term beneficial effects of platelet-rich plasma for non-insertional Achilles tendinopathy.
Guelfi M; Pantalone A; Vanni D; Abate M; Guelfi MG; Salini V
Foot Ankle Surg; 2015 Sep; 21(3):178-81. PubMed ID: 26235856
[TBL] [Abstract][Full Text] [Related]
5. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells.
van den Dolder J; Mooren R; Vloon AP; Stoelinga PJ; Jansen JA
Tissue Eng; 2006 Nov; 12(11):3067-73. PubMed ID: 17518622
[TBL] [Abstract][Full Text] [Related]
6. Platelet-rich plasma application in the management of chronic tendinopathies.
Kaux JF; Crielaard JM
Acta Orthop Belg; 2013 Feb; 79(1):10-5. PubMed ID: 23547508
[TBL] [Abstract][Full Text] [Related]
7. The use of platelet-rich plasma to treat chronic tendinopathies: A technical analysis.
Kaux JF; Emonds-Alt T
Platelets; 2018 May; 29(3):213-227. PubMed ID: 28759287
[TBL] [Abstract][Full Text] [Related]
8. Does Platelet-Rich Plasma Increase Tendon Metabolism?
de Vos RJ
Adv Exp Med Biol; 2016; 920():263-73. PubMed ID: 27535268
[TBL] [Abstract][Full Text] [Related]
9. [Chronic tendinopathies and platelet-rich plasma].
Kaux JF; Drion P; Croisier JL; Colige A; Libertiaux V; Gothot A; Crielaard JM
Rev Med Liege; 2014; 69 Spec No():72-7. PubMed ID: 25796803
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in amount of growth factors secreted by platelets in platelet-rich plasma samples from alopecia patients.
Shaik JA; Estharabadi N; Farah RS; Hordinsky MK
Exp Dermatol; 2020 Oct; 29(10):1004-1011. PubMed ID: 32748436
[TBL] [Abstract][Full Text] [Related]
11. Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells.
Perut F; Filardo G; Mariani E; Cenacchi A; Pratelli L; Devescovi V; Kon E; Marcacci M; Facchini A; Baldini N; Granchi D
Cytotherapy; 2013 Jul; 15(7):830-9. PubMed ID: 23731763
[TBL] [Abstract][Full Text] [Related]
12. The Properties of 3 Different Plasma Formulations and Their Effects on Tendinopathic Cells.
Rubio-Azpeitia E; Bilbao AM; Sánchez P; Delgado D; Andia I
Am J Sports Med; 2016 Aug; 44(8):1952-61. PubMed ID: 27161868
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tendinopathies with platelet-rich plasma.
Mautner K; Kneer L
Phys Med Rehabil Clin N Am; 2014 Nov; 25(4):865-80. PubMed ID: 25442163
[TBL] [Abstract][Full Text] [Related]
14. Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway.
Mammoto T; Jiang A; Jiang E; Mammoto A
Microvasc Res; 2013 Sep; 89():15-24. PubMed ID: 23660186
[TBL] [Abstract][Full Text] [Related]
15. Advances with platelet rich plasma therapies for tendon regeneration.
Andia I; Martin JI; Maffulli N
Expert Opin Biol Ther; 2018 Apr; 18(4):389-398. PubMed ID: 29300106
[TBL] [Abstract][Full Text] [Related]
16. Growth factors in the management of sport-induced tendinopathies: results after 24 months from treatment. A pilot study.
Volpi P; Quaglia A; Schoenhuber H; Melegati G; Corsi MM; Banfi G; de Girolamo L
J Sports Med Phys Fitness; 2010 Dec; 50(4):494-500. PubMed ID: 21178936
[TBL] [Abstract][Full Text] [Related]
17. Injectable agents derived from or targeting vascularity: has clinical acceptance in managing tendon disorders superseded scientific evidence?
Hoksrud AF; Bahr R
J Musculoskelet Neuronal Interact; 2011 Jun; 11(2):174-84. PubMed ID: 21625054
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
[TBL] [Abstract][Full Text] [Related]
19. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression.
McCarrel T; Fortier L
J Orthop Res; 2009 Aug; 27(8):1033-42. PubMed ID: 19170097
[TBL] [Abstract][Full Text] [Related]
20. Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes.
Andia I; Rubio-Azpeitia E; Maffulli N
Clin Orthop Relat Res; 2015 May; 473(5):1624-34. PubMed ID: 25670657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
